Palmitoyl tetrapeptide-7 is a synthetic peptide compound that combines several chains of amino acids to reduce skin inflammation and skin damage. This compound is believed to stimulate the regeneration of collagen fibers in the dermis by acting as a cellular messenger. Palmitoyl tetrapeptide-7 is thought to increase the amount of hyaluronic acid in the skin, helping to tighten the skin by attracting moisture to the epidermis and is therefore used the cosmetic industry in anti-aging products.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Inactive ingredient | Mary Kay Timewise Repair Volu-Firm The Go Set Approved Usehelps prevent sunburn. If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun |
| Substance Class |
Protein
Created
by
admin
on
Edited
Wed Apr 02 21:21:05 GMT 2025
by
admin
on
Wed Apr 02 21:21:05 GMT 2025
|
| Protein Type | PEPTIDE |
| Protein Sub Type | |
| Sequence Type | COMPLETE |
| Record UNII |
Q41S464P1R
|
| Record Status |
FAILED
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000181213
Created by
admin on Wed Apr 02 21:21:05 GMT 2025 , Edited by admin on Wed Apr 02 21:21:05 GMT 2025
|
PRIMARY | |||
|
DTXSID10176644
Created by
admin on Wed Apr 02 21:21:05 GMT 2025 , Edited by admin on Wed Apr 02 21:21:05 GMT 2025
|
PRIMARY | |||
|
Q41S464P1R
Created by
admin on Wed Apr 02 21:21:05 GMT 2025 , Edited by admin on Wed Apr 02 21:21:05 GMT 2025
|
PRIMARY | |||
|
Q41S464P1R
Created by
admin on Wed Apr 02 21:21:05 GMT 2025 , Edited by admin on Wed Apr 02 21:21:05 GMT 2025
|
PRIMARY | |||
|
SUB194729
Created by
admin on Wed Apr 02 21:21:05 GMT 2025 , Edited by admin on Wed Apr 02 21:21:05 GMT 2025
|
PRIMARY | |||
|
10078408
Created by
admin on Wed Apr 02 21:21:05 GMT 2025 , Edited by admin on Wed Apr 02 21:21:05 GMT 2025
|
PRIMARY | |||
|
DB14137
Created by
admin on Wed Apr 02 21:21:05 GMT 2025 , Edited by admin on Wed Apr 02 21:21:05 GMT 2025
|
PRIMARY | |||
|
221227-05-0
Created by
admin on Wed Apr 02 21:21:05 GMT 2025 , Edited by admin on Wed Apr 02 21:21:05 GMT 2025
|
PRIMARY | |||
|
1314277
Created by
admin on Wed Apr 02 21:21:05 GMT 2025 , Edited by admin on Wed Apr 02 21:21:05 GMT 2025
|
PRIMARY | RxNorm |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO_ACID_SUBSTITUTION | N-TERMINUS | PALMITOYL GLYCINE | M6V3RIU5KI |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|